EMEA-001563-PIP02-15-M01

Key facts

Active substance
Ciprofloxacin (hydrochloride)
Therapeutic area
Infectious diseases
Decision number
P/0253/2018
PIP number
EMEA-001563-PIP02-15-M01
Pharmaceutical form(s)
Nebuliser solution
Condition(s) / indication(s)
Treatment of chronic pulmonary infections caused by Pseudomonas aeruginosa
Route(s) of administration
Inhalation use
Contact for public enquiries
Savara ApS

E-mail: mette.vinge@savarapharma.com
Tel. +45 2488 5979

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating